Mice Model Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The Mice Model Market is Segmented by Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid Mice, Surgically Modified Mice, and Spontaneous Mutant Mice), Service (Breeding, Cryopreservation, Model in-Licensing, Genetic Testing, and Other Services), Technology (CRISPR/CAS9, Embryonic Stem Cell Injection, Nuclear Transfer, and Other Technologies), Application (Oncology, Cardiovascular Studies, Neurology, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Mice Model Market Size

Mice Model Market Summary
share button
Study Period 2018 - 2028
Base Year For Estimation 2022
Forecast Data Period 2023 - 2028
CAGR 6.80 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Mice Model Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Mice Model Market Analysis

The mice model market is expected to register a CAGR of 6.8% over the forecast period.

  • The COVID-19 pandemic had a significant impact on the market studied. Research laboratories and biopharmaceutical industries extensively used mice models in preclinical development. For instance, according to an article published by Methods of Molecular Biology in October 2022, a small rodent animal model using K18 hACE2 transgenic mice had been represented as an option to understand the pathogenicity of natural SARS-CoV-2 strains. It had been described as a Variants of Concern (VoC) that applied to the identification and characterization of prophylactic (vaccine) and therapeutic (antiviral and neutralizing monoclonal antibodies) strategies for the prevention or treatment of SARS-CoV-2 infection or its associated COVID-19 disease. Thus, the adoption of mouse models to analyze the progress made since the discovery of SARS-CoV-2 in developing and applying relevant mouse models had been anticipated to drive market growth during the pandemic. However, as the COVID-19 cases started to decline, the market had begun to show average pre-pandemic level growth and was likely to continue its significant growth rate during the forecast period.
  • Factors such as increasing innovations in mice models, rising demand for personalized medicine, and a growing pipeline of pharmaceutical and biopharmaceutical companies are driving the growth of the mice model market. For instance, an article published by Molecular Neurodegeneration in June 2022 stated that the genetic engineering of novel mouse models using knock-in approaches addresses some of the limitations of genetic mutations. Also, the article mentioned in its conclusion that the scientific community should use the open-access mouse model as a resource to study disease-relevant biology. Thus, such instances are anticipated to boost the demand for mice models, further driving the market growth.
  • In addition, the rising demand for precision medicine is driving the growth. For instance, in April 2022, an article published in the journal Nature Medicine reported that the increasing use of genomic profiling for diagnosis and therapy guidance in many tumor types had increased the use of precision medicine in cancer patients. With the increased demand for precision medicine, the utilization of mouse models will also increase, leading to market growth.
  • Furthermore, several key market players have also been investing in the market's growth. For instance, in January 2022, Inotiv acquired Orient BioResource Center, Inc. from Orient Bio, Inc., a preclinical CRO and animal model supplier based in Seongnam, South Korea. Orient BioResource Center is a primate quarantine & holding facility located near Alice, Texas.
  • Hence, as per the abovementioned factors, the mice model market is anticipated to grow over the forecast period. However, alternatives to animal testing and regulations for the ethical use of animals are expected to restrain the market's growth.

Mice Model Market Trends

The Oncology Segment is Expected to Hold a Significant Market Share Over the Forecast Period

  • The primary factor propelling the oncology segment's growth is the rising burden of cancer, coupled with the increasing adoption of mice models in various oncology-related drug and vaccine development research. For instance, in February 2021, ExpreS2ion Biotech Holding and the University of Bologna entered into a research collaboration agreement that covers testing of the novel HER2-cVLP breast cancer vaccine program, including the selected lead candidate ES2B-C001 in proprietary state-of-the-art breast cancer mice models.
  • In addition, the increasing research using mice models for drug discovery for cancer is also anticipated to contribute to the market growth. For example, as per the article published by OncoImmunology in April 2022, the researchers utilized the Diversity Outbred (DO) and Collaborative Cross (CC) mouse models to investigate the outcomes of the immune checkpoint inhibitors (ICI) for a variety of malignancies. The study researchers purchased the DO mice models from the Jackson Laboratory and all CC mice from the Systems Genetics Core Facility at the University of North Carolina. Such adoption of mice models in cancer research is expected to contribute to segment growth.
  • Product launches by the key market players support the market growth over the forest period. For instance, in January 2023, Taconic Biosciences launched the huNOG-EXL EA (Early Access) humanized immune system (HIS) mouse. This product expands Taconic's widely used HIS portfolio. huNOG-EXL EA significantly lengthens the study window during which a myeloid-lineage HIS mouse model can be used successfully.
  • Thus, the abovementioned factor is expected to boost the segment growth over the forecast period.
Mice Model Market: Estimated Number of Cancer Cases of all Ages (in Thousand), United States, 2022-2023

North America is Expected to Hold a Significant Growth in the Mice Model Market

  • North America is anticipated to witness growth over the forecast period due to increased healthcare expenditure, increased research and development, and a rising prevalence of infectious or non-communicable diseases. The market players in the country are involved in multiple activities, such as collaborations and agreements, which are anticipated to drive market growth over the forecast period. 
  • For instance, in May 2021, the SDS Alliance launched a Mouse Model Project with the Jackson Laboratory. The project will create the mouse model (introduce SDS disease genes into mice using CRISPR and breed) for USD 150,000 and characterize the model (such as how SDS present in mice compared to human SDS or whether the mice get pancreatic problems or neutropenia) for another USD 150,000.
  • In addition, in November 2021, Tranquis Therapeutics, a private immuno-neurology company, declared positive preclinical data on its lead program TQS-168 at the Neuroscience 2021 meeting. The data illustrate the potential of TQS-168 for treating amyotrophic lateral sclerosis (ALS). TQS-168 showed increased median survival and decreased pro-inflammatory cytokines and inflammatory monocytes in a widely used SOD1-G93A transgenic mouse model and demonstrated a similar decrease in inflammatory monocytes in blood from ALS patients. Such advances in the region are anticipated to fuel market growth.
  • Therefore, owing to the abovementioned factors, North America is predicted to witness growth over the forecast period.
Mice Model Market - Growth Rate by Region

Mice Model Industry Overview

The mice model market is moderately concentrated in nature due to the presence of companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known, including Allentown LLC, Charles River Laboratories International Inc., ENVIGO, Genoway, Harbour Biomed, and The Jackson Laboratory, among others.

Mice Model Market Leaders

  1. genOway

  2. Charles River

  3. Taconic Biosciences Inc.

  4. Envigo

  5. The Jackson Laboratory

*Disclaimer: Major Players sorted in no particular order

Mice Model Market Concentration

Mice Model Market News

  • July 2022: GemPharmatech entered into a strategic license agreement with Charles River Laboratories, Inc. to exclusively distribute its next-generation NOD CRISPR Prkdc Il2r gamma (NCG)-mouse lines in North America. Charles River is planning to establish foundation colonies with models to be commercially available at the beginning of 2023.
  • April 2022: The Medical Research Council (MRC) of the United Kingdom officially launched the National Mouse Genetics Network with an investment of Euro 20 million. The MRC National Mouse Genetics Network was formed to focus on mouse genetics for disease modeling, which is predicted to capitalize on the United Kingdom's international excellence in the biomedical sciences. The Network comprises seven research clusters, with members distributed across the country.

Mice Model Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Innovation in Mice Models

      2. 4.2.2 Rising Demand for Personalized Medicine

      3. 4.2.3 Growing Pipeline of Pharmaceutical and Biophamraceutical Companies

    3. 4.3 Market Restraints

      1. 4.3.1 Alternatives to Animal Testing

      2. 4.3.2 Regulations for the Ethical Use of Animals

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Type

      1. 5.1.1 Inbred Mice

      2. 5.1.2 Outbred Mice

      3. 5.1.3 Genetically Engineered Mice

      4. 5.1.4 Hybrid/Congenic Mice

      5. 5.1.5 Other Types

    2. 5.2 By Service

      1. 5.2.1 Breeding

      2. 5.2.2 Cryopreservation

      3. 5.2.3 Model in-Licensing

      4. 5.2.4 Genetic Testing

      5. 5.2.5 Other Services

    3. 5.3 By Technology

      1. 5.3.1 CRISPR/CAS9

      2. 5.3.2 Embryonic Stem Cell Injection

      3. 5.3.3 Nuclear Transfer

      4. 5.3.4 Other Technologies

    4. 5.4 By Application

      1. 5.4.1 Oncology

      2. 5.4.2 Cardiovascular Studies

      3. 5.4.3 Neurology

      4. 5.4.4 Other Applications

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle East and Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle East and Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allentown LLC

      2. 6.1.2 Charles River Laboratories International Inc.

      3. 6.1.3 ENVIGO

      4. 6.1.4 Genoway

      5. 6.1.5 Harbour Biomed

      6. 6.1.6 Horizon Discovery Group PLC (Sage Labs Inc.)

      7. 6.1.7 Ingenious Targeting Laboratory

      8. 6.1.8 Janvier Labs

      9. 6.1.9 Ozgene Pty Ltd

      10. 6.1.10 PolyGene

      11. 6.1.11 Taconic Biosciences Inc.

      12. 6.1.12 The Andersons Inc.

      13. 6.1.13 The Jackson Laboratory

      14. 6.1.14 Trans Genic Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

Mice Model Industry Segmentation

Mice models are biological representations of human diseases or syndromes. Mice and humans have approximately 99% similarity in their DNA. By studying mice that have symptoms of diseases like Alzheimer's, diabetes, or cancer, we can learn a lot more about how these diseases might be treated in patients.

The mice model market is segmented by type (inbred mice, outbred mice, genetically engineered mice, hybrid mice, surgically modified mice, and spontaneous mutant mice), service (breeding, cryopreservation, model in-licensing, genetic testing, and other services), technology (CRISPR/CAS9, embryonic stem cell injection, nuclear transfer, and other technologies), application (oncology, cardiovascular studies, neurology, and other applications), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.

The report offers the value (in USD) for the above segments.

By Type
Inbred Mice
Outbred Mice
Genetically Engineered Mice
Hybrid/Congenic Mice
Other Types
By Service
Breeding
Cryopreservation
Model in-Licensing
Genetic Testing
Other Services
By Technology
CRISPR/CAS9
Embryonic Stem Cell Injection
Nuclear Transfer
Other Technologies
By Application
Oncology
Cardiovascular Studies
Neurology
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Mice Model Market Research FAQs

The Mice Model Market is studied from 2018 - 2028.

The Mice Model Market is growing at a CAGR of 6.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2018 - 2028.

North America holds highest share in 2022.

genOway, Charles River, Taconic Biosciences Inc., Envigo, The Jackson Laboratory are the major companies operating in Mice Model Market.

Global Mice Model Industry Report

Statistics for the 2023 Mice Model market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Mice Model analysis includes a market forecast outlook to for 2023 to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!